botulinum toxin type a

FDA Drug Profile

botulinum toxin type a is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug details

Generic Name
botulinum toxin type a
Sponsor
Allergan, Inc.
NDC Codes
1
Dosage Forms
POWDER
Active Ingredients
BOTULINUM TOXIN TYPE A

Indications and Usage

1 INDICATIONS AND USAGE DAXXIFY is an acetylcholine release inhibitor and neuromuscular-blocking agent indicated for: Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/ or procerus muscle activity in adult patients. ( 1.1 ) The treatment of cervical dystonia in adult patients. ( 1.2 ) 1.1 Glabellar Lines DAXXIFY is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. 1.2 Cervical Dystonia DAXXIFY is indicated for the treatment of cervical dystonia in adult patients.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.